To further confirm whether SDT with down-regulation of MDR1 by celecoxib augments anti-tumor effects, we assessed the efficacy in the mouse GSC-bearing glioma model (Fig. 4a). This evidence concerns the gene ABCB1 and central nervous system cancer.